Grace Blest-Hopley

Dr Grace Blest-Hopley is a neuroscientist with more than ten years’ experience researching cannabinoids and psychedelics. She completed her PhD in neuroscience at King’s College London and is Chief Scientific Officer at NWPharma Tech and Research Director at the Heroic Hearts Project, which explores psychedelic therapies for military veterans living with trauma. She is also the founder and CEO of Hystelica, a research organisation investigating how female biology influences the safety and effectiveness of psychedelics.